Who is sponsoring NCT02003482?

NCT02003482 is sponsored by University of Miami.

What drugs are being tested in NCT02003482?

Interventions in NCT02003482: Postop IMRT for head/neck cancer, CT for Radiation Treatment Planning.

What condition does NCT02003482 study?

NCT02003482 studies Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma.

Is NCT02003482 still recruiting?

NCT02003482 is currently completed. Last updated 29 March 2018.

Last reviewed 2018-03-29 · How we verify

NCT02003482

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Prospective Trial of Serial CT Imaging for Evaluation of Dosimetric/Volumetric Changes During IMRT for Head/Neck Cancer

Completed Last updated 29 March 2018

What this trial tests

trial testing Postop IMRT for head/neck cancer in Head and Neck Cancer in 39 participants. Completed in 26 March 2018.

Timeline

9 May 2006

Primary endpoint
26 March 2018

26 March 2018

Quick facts

Lead sponsor	University of Miami
Status	Completed
Study type	OBSERVATIONAL
Enrollment	39
Start date	9 May 2006
Primary completion	26 March 2018
Estimated completion	26 March 2018
Sites	1 location across United States

Drugs / interventions tested

Postop IMRT for head/neck cancer
CT for Radiation Treatment Planning

Conditions studied

Head and Neck Cancer — all drugs for Head and Neck Cancer →
Head and Neck Squamous Cell Carcinoma — all drugs for Head and Neck Squamous Cell Carcinoma →

Sponsor

University of Miami

Who can join

18 and older, any sex, with Head and Neck Cancer or Head and Neck Squamous Cell Carcinoma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Anatomical changes that take place during Intensity modulated radiation therapy (IMRT) treatments for cancers of the head and neck cause significant dosimetric changes.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Prospective Pilot Study Comparing the Need for Adaptive Radiotherapy in Unresected Bulky Disease and in Postoperative Patients With Head and Neck Cancer.
Mahmoud O, Reis IM, Samuels MM, Elsayyad N, et al · · 2017 · cited 19× · PMID 28671024 · DOI 10.1177/1533034617717624

Verify or expand the search:

Other recruiting trials for Head and Neck Cancer

Currently open trials in the same condition.

NCT07318220 — Prehabilitation Protocol for Head and Neck Cancer Patients · NA · recruiting
NCT07524114 — Study of High-Precision Evaluation of Molecular ResiduaL Disease Through a PlatfOrm for Cancer TracKing and Interception · recruiting
NCT07467083 — Development and Application of a Nurse-Led Preemptive Symptom Management Protocol for Head and Neck Cancer Patients Unde · Phase 3 · recruiting
NCT07209189 — Neoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatment De-esca · Phase 2 · recruiting
NCT06837480 — Photobiomodulation in Head and Neck Cancer-Related Chronic Lymphedema · NA · recruiting

Other University of Miami trials

Trials by the same sponsor.

NCT06003712 — Exploring the Effect of Mindfulness on Quality of Life (QoL) in Spinal Cord Injury (SCI) · NA · not yet recruiting
NCT06077071 — MRIdian "RADAR" Trial · NA · not yet recruiting
NCT07472413 — Alternate Pre-med in Anti-Cluster of Differentiation 20 (CD20) Pilot Project · Phase 3 · not yet recruiting
NCT07322289 — Antibiotic-coated Braided Suture Study · NA · not yet recruiting
NCT07469592 — eHealth Mindfulness-based Music Therapy Intervention for Patients Undergoing Stem Cell Transplantation · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02003482 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Miami
Last refreshed: 29 March 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02003482.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing